The Antibody Medicines Conjugate (ADC) Medicines Market is rapidly emerging as one of the most transformative segments within oncology therapeutics. ADCs combine the targeting ability of monoclonal antibodies with the cancer-killing power of cytotoxic Mediciness, creating highly precise treatment options that minimize damage to healthy cells. With rising cancer incidence worldwide and...